Glycopyrrolate 0.2 MG/ML Injectable Solution — RxCUI 238212
RxNorm drug concept · Semantic clinical drug
RxCUI 238212
Semantic clinical drug · SCD
● Current RxNorm concept 95 FDA products
105 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI238212
Official nameGlycopyrrolate 0.2 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped95
Package NDCs mapped105
Reported Medicaid activity (SDUD)40,388 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Glycopyrronium Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Qbrexza is a medicated cloth you wipe under your arms once a day. It contains glycopyrronium, which blocks the signal your nerves send to your sweat glands. The result is that your...
- What exactly is Qbrexza and what is it supposed to do?
- Each pouch holds one pre-moistened cloth. Tear it open, unfold the cloth, and wipe it across one underarm once — then use that same cloth on your other underarm. Apply it to clean,...
- Dry mouth is the most common one — about 1 in 4 people in trials noticed it. You might also experience blurred vision, dilated pupils, mild difficulty urinating, headache, or dryne...
🕸️ Concept Web — How Glycopyrrolate 0.2 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Glycopyrrolate 0.2 MG/ML Injectable Solution
RxCUI 238212 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Glycopyrronium
1546438IN -
Glycopyrrolate
4955PIN
-
Glycopyrronium
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glycopyrronium Injectable Solution
372339SCDF -
Glycopyrrolate Injectable Solution
2645610SCDFP -
Glycopyrronium Injectable Product
2109869SCDG -
Glycopyrrolate Injectable Product
2661860SCDGP -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Glycopyrronium Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glycopyrrolate 0.2 MG/ML
315999SCDC
-
Glycopyrrolate 0.2 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glycopyrrolate 0.2 MG/ML
SCDC · 315999 -
Glycopyrronium Injectable Solution
SCDF · 372339 -
Glycopyrrolate Injectable Solution
SCDFP · 2645610 -
Glycopyrronium Injectable Product
SCDG · 2109869 -
Glycopyrrolate Injectable Product
SCDGP · 2661860
📦 FDA Products & Package NDCs
95 products · 105 package NDCs
105 package NDCs map to RxCUI 238212 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9584-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0143-9584-10) / 20 mL in 1... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2015-06-01 |
| 00143-9585-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (0143-9585-25) / 5 mL in 1... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2015-06-01 |
| 00143-9586-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9586-25) / 2 mL in 1... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2015-06-01 |
| 00143-9587-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9587-25) / 1 mL in 1... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2015-06-01 |
| 00143-9679-10 | 10 VIAL in 1 CARTON (0143-9679-10) / 20 mL in 1 VIAL (0143-... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2011-09-21 |
| 00143-9680-25 | 25 VIAL in 1 CARTON (0143-9680-25) / 5 mL in 1 VIAL (0143-9... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2011-09-21 |
| 00143-9681-25 | 25 VIAL in 1 CARTON (0143-9681-25) / 2 mL in 1 VIAL (0143-9... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2011-09-21 |
| 00143-9682-25 | 25 VIAL in 1 CARTON (0143-9682-25) / 1 mL in 1 VIAL (0143-9... | Glycopyrrolate | Hikma Pharmaceuticals USA Inc. | 2011-09-21 |
| 00404-9776-05 | 1 VIAL, GLASS in 1 BAG (0404-9776-05) / 1 mL in 1 VIAL, GLA... | Glycopyrrolate | Henry Schein, Inc. | 2025-11-05 |
| 00404-9777-20 | 1 VIAL, GLASS in 1 BAG (0404-9777-20) / 1 mL in 1 VIAL, GLA... | Glycopyrrolate | Henry Schein, Inc. | 2025-11-05 |
| 00517-4601-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4601-25) / 1 mL in 1 V... | Glycopyrrolate | American Regent, Inc. | 1990-09-30 |
| 00517-4602-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4602-25) / 2 mL in 1 V... | Glycopyrrolate | American Regent, Inc. | 1990-09-30 |
| 00517-4605-25 | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-4605-25) / 5 mL in 1 VI... | Glycopyrrolate | American Regent, Inc. | 1990-09-30 |
| 00517-4620-25 | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-4620-25) / 20 mL in 1 V... | Glycopyrrolate | American Regent, Inc. | 1990-09-30 |
| 00781-3825-96 | 25 VIAL in 1 CARTON (0781-3825-96) / 1 mL in 1 VIAL (0781-3... | Glycopyrrolate | Sandoz Inc | 2019-07-22 |
| 00781-3827-96 | 25 VIAL in 1 CARTON (0781-3827-96) / 2 mL in 1 VIAL (0781-3... | Glycopyrrolate | Sandoz Inc | 2019-07-22 |
| 00781-3829-96 | 25 VIAL in 1 CARTON (0781-3829-96) / 5 mL in 1 VIAL (0781-3... | Glycopyrrolate | Sandoz Inc | 2019-07-22 |
| 00781-3831-95 | 10 VIAL in 1 CARTON (0781-3831-95) / 20 mL in 1 VIAL (0781-... | Glycopyrrolate | Sandoz Inc | 2019-07-22 |
| 16729-0471-08 | 25 VIAL, SINGLE-DOSE in 1 CARTON (16729-471-08) / 1 mL in 1... | Glycopyrrolate | Accord Healthcare, Inc., | 2020-12-17 |
| 16729-0472-08 | 25 VIAL, SINGLE-DOSE in 1 CARTON (16729-472-08) / 2 mL in 1... | Glycopyrrolate | Accord Healthcare, Inc., | 2020-12-10 |
| 16729-0473-03 | 10 VIAL, MULTI-DOSE in 1 CARTON (16729-473-03) / 5 mL in 1... | Glycopyrrolate | Accord Healthcare, Inc., | 2020-12-17 |
| 16729-0474-03 | 10 VIAL, MULTI-DOSE in 1 CARTON (16729-474-03) / 20 mL in 1... | Glycopyrrolate | Accord Healthcare, Inc., | 2020-12-10 |
| 25021-0796-01 | 10 VIAL in 1 CARTON (25021-796-01) / 1 mL in 1 VIAL | Glycopyrrolate | Sagent Pharmaceuticals | 2024-10-15 |
| 25021-0796-02 | 10 VIAL in 1 CARTON (25021-796-02) / 2 mL in 1 VIAL | Glycopyrrolate | Sagent Pharmaceuticals | 2024-11-15 |
| 25021-0796-05 | 10 VIAL in 1 CARTON (25021-796-05) / 5 mL in 1 VIAL | Glycopyrrolate | Sagent Pharmaceuticals | 2024-11-15 |
| 51662-1425-01 | 1 mL in 1 VIAL (51662-1425-1) | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-21 |
| 51662-1431-01 | 5 mL in 1 VIAL (51662-1431-1) | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-21 |
| 51662-1484-01 | 20 mL in 1 VIAL (51662-1484-1) | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 2020-01-11 |
| 51662-1601-01 | 5 mL in 1 VIAL (51662-1601-1) | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 2022-08-29 |
| 51662-1601-03 | 25 POUCH in 1 CASE (51662-1601-3) / 1 VIAL in 1 POUCH (5166... | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 2023-01-19 |
| 55150-0292-01 | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-292-01) / 1 mL in 1... | Glycopyrrolate | AuroMedics Pharma LLC | 2018-11-28 |
| 55150-0293-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-293-02) / 2 mL in 1... | Glycopyrrolate | AuroMedics Pharma LLC | 2018-11-28 |
| 55150-0294-05 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-294-05) / 5 mL in 1... | Glycopyrrolate | AuroMedics Pharma LLC | 2018-11-28 |
| 55150-0295-20 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-295-20) / 20 mL in 1... | Glycopyrrolate | AuroMedics Pharma LLC | 2018-11-28 |
| 62332-0607-25 | 25 VIAL in 1 CARTON (62332-607-25) / 1 mL in 1 VIAL (62332-... | Glycopyrrolate | Alembic Pharmaceuticals Inc. | 2022-10-26 |
| 62332-0627-25 | 25 VIAL in 1 CARTON (62332-627-25) / 2 mL in 1 VIAL (62332-... | Glycopyrrolate | Alembic Pharmaceuticals Inc. | 2022-10-26 |
| 62332-0628-25 | 25 VIAL in 1 CARTON (62332-628-25) / 5 mL in 1 VIAL (62332-... | Glycopyrrolate | Alembic Pharmaceuticals Inc. | 2022-10-26 |
| 62332-0629-10 | 10 VIAL in 1 CARTON (62332-629-10) / 20 mL in 1 VIAL (62332... | Glycopyrrolate | Alembic Pharmaceuticals Inc. | 2022-10-26 |
| 63323-0578-01 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-01) / 1 mL in 1... | Glycopyrrolate | Fresenius Kabi USA, LLC | 2017-10-27 |
| 63323-0578-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-02) / 2 mL in 1... | Glycopyrrolate | Fresenius Kabi USA, LLC | 2017-10-27 |
| 63323-0578-05 | 25 VIAL, MULTI-DOSE in 1 CARTON (63323-578-05) / 5 mL in 1... | Glycopyrrolate | Fresenius Kabi USA, LLC | 2017-10-27 |
| 63323-0578-11 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-11) / 1 mL in 1... | Glycopyrrolate | Fresenius Kabi USA, LLC | 2017-10-27 |
| 63323-0578-12 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-12) / 2 mL in 1... | Glycopyrrolate | Fresenius Kabi USA, LLC | 2017-10-27 |
| 65145-0102-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-102-25) / 1 mL in 1... | Glycopyrrolate | Caplin Steriles Limited | 2025-01-25 |
| 65145-0103-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-103-25) / 2 mL in 1... | Glycopyrrolate | Caplin Steriles Limited | 2025-01-25 |
| 65145-0104-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (65145-104-25) / 5 mL in 1... | Glycopyrrolate | Caplin Steriles Limited | 2025-01-25 |
| 65145-0105-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-105-10) / 20 mL in 1... | Glycopyrrolate | Caplin Steriles Limited | 2025-01-25 |
| 66794-0202-42 | 25 VIAL, GLASS in 1 CARTON (66794-202-42) / 1 mL in 1 VIAL,... | Glycopyrrolate | Piramal Critical Care Inc | 2019-07-11 |
| 66794-0203-42 | 25 VIAL, GLASS in 1 CARTON (66794-203-42) / 2 mL in 1 VIAL,... | Glycopyrrolate | Piramal Critical Care Inc | 2019-07-11 |
| 66794-0204-42 | 25 VIAL, GLASS in 1 CARTON (66794-204-42) / 5 mL in 1 VIAL,... | Glycopyrrolate | Piramal Critical Care Inc | 2019-07-11 |
Observed labelers:
Medical Purchasing Solutions, LLC (9) ·
Hikma Pharmaceuticals USA Inc. (8) ·
Meitheal Pharmaceuticals Inc. (8) ·
Somerset Therapeutics, LLC (8) ·
Fresenius Kabi USA, LLC (5) ·
HF Acquisition Co LLC, DBA HealthFirst (5)
· +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1596 | Inj, glycopyrrolate, 0.1 mg | 56 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.